Genethon
Business Services · France · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
1 bis Rue De L'internationale, Evry, Ile...Phone Number
+33 169472828Website
www.genethon.frRevenue
$88.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Genethon
Généthon is dedicated to advancing gene therapy treatments for rare diseases, focusing on conditions affecting the eye, liver, immune system, and neuromuscular diseases. The company develops innovative therapies and conducts clinical trials to provide effective treatments for patients suffering from various genetic disorders. Their extensive pipeline includes therapies for conditions such as Duchenne muscular dystrophy, sickle cell disease, and Fanconi anemia. Généthon aims to make these groundbreaking treatments accessible to patients in need, contributing to the public interest in the field of gene therapy.Explore more
Popular SearchesGenethonGénéthonG?n?thonSIC Code 87,873NAICS Code 54,541Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genethon your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Genethon has new funding data
Earning: See what the market has to say on Genethon recently announced quarterly report
Check out if Genethon is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Genethon
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Genethon launches new products
Genethon, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Genethon had a recent Job posting/layoffs
Check if Genethon has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Genethon as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Genethon is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Genethon is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Genethon.
Genethon Tech Stack
A closer look at the technologies used by Genethon
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Event
Person-Based
Events, Search, Medical Research
Event
Person-Based
Genethon News & Media
Genethon Celebrates Rare Disease Day by Highlighting New Technologies to Advance Gene Therapies and Bring Hope to Millions of Patients Worldwide
PARIS--(BUSINESS WIRE)--Genethon Celebrates Rare Disease Day by Highlighting New TechnologiesA Phase 3 Ready DMD Gene Therapy, a Clinical Trial to Offset AAV Neutralizing Antibodies, and an AI Inspired New Generation of Capsids Highlight Genethon’s 2024 Fall Milestones
PARIS--(BUSINESS WIRE)--Genethon's GNT0004, a gene therapy for Duchene muscular dystrophy, has been given the green light to proceed with Phase 3 pivotal trials.Genethon and Hansa Biopharma announce initiation of a Phase 2 trial of imlifidase as a pre-treatment to GNT-0003 in severe Crigler-Najjar syndrome
The trial will be conducted in patients with pre-existing anti-AAV antibodies which limit use of gene therapy treatment Lund, Sweden and Evry, France 3 December 2024. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA) and Genethon, a pioneer and a leader in gene therapy research and development for rare genetic diseases, today announced initiation of GNT-018-IDES, a Phase 2 trial in patients with Crigler-Najjar syndrome with pre-existing antibodies against adeno-associated virus (AAV) vectors. Th
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genethon
Sign Up For FreeTo access detailed company insights
Généthon is dedicated to advancing gene therapy treatments for rare diseases, focusing on conditions affecting the eye, liver, immune system, and neuromuscular diseases. The company develops innovative therapies and conducts clinical trials to provide effective treatments for patients suffering from various genetic disorders. Their extensive pipeli... Read More
